Danone reports sales of US$8.21B in Q2 2026

FRANCE – Danone has reported sales of US$8.21 billion (€7.22 billion), up +4.2% LFL, with a contribution of +1.9% from volume/mix and +2.3% from price in Q2 2026.

On a reported basis, sales increased by +4.4%, including a positive scope effect of +0.8%, mainly reflecting the consolidation of Kate Farms in the Americas and of the joint venture with Saputo Dairy Australia in APAC, and a negative impact of currencies (-1.0%).

Additionally, both hyperinflation (+0.2%) and the application of IAS29 (+0.1%) contributed positively to reported sales.

In H1 2026, sales stood at US$15.8 billion (€13.9 billion), up +3.5% LFL, with a contribution of +1.7% from volume/mix and +1.8% from price.

On a reported basis, sales increased by +1.4%, including a positive scope effect of +0.7%, mainly reflecting the consolidation of Kate Farms and of the joint venture with Saputo Dairy Australia, and a negative impact of currencies (-3.3%).

Both hyperinflation (+0.3%) and the application of IAS29 (+0.5%) had a positive effect on reported net sales.

In Q2 2026, EMEA sales were up +3.6% LFL, led by volume/mix at +2.2% and price at +1.5%. Within the region, Europe delivered LFL sales growth of +0.6%, with volume/mix at +0.3% and price at +0.3%.

EDP showed continued momentum across the region, with functional dairy and Alpro in strong demand. Specialized Nutrition delivered an improved performance supported by a catch-up in the Middle East and a progressive recovery in Europe throughout Q2. Waters delivered a solid start to the summer season, led by Volvic.

In the Americas, sales were up +4.3% LFL in Q2, with volume/mix at +0.3% and price up +4.0%. Within the region, North America posted LFL sales growth of +2.6%, with volume/mix at +0.7% and price at +2.0%.

EDP delivered a solid performance across the region, driven by functional yogurts. North America saw progressive improvement, with continued strong growth in High Protein and better momentum in creamers.

In Specialized Nutrition, both Medical Nutrition – driven by Neocate – and IMF across Latin America delivered competitive doubledigit growth. In Asia Pacific, LFL sales were up +5.2% in Q2, led by volume/mix at +3.5% and price at +1.6%.

Within the region, China, North Asia & Oceania (CNAO) posted LFL sales growth of +3.6% with volume/mix at +1.5% and price at +2.2%.

Specialized Nutrition delivered a solid performance, with competitive growth in IMF China amid a normalizing category.

EDP Japan saw continued strong activation driving demand for Oikos and Activia, while the performance in Waters reflected a mix of strong, competitive growth with Aqua in Indonesia and soft category for Mizone in China.

To receive our email newsletters with the latest news and insights from Africa, the Middle East and around the world, SUBSCRIBE HERE